Coronavirus (Covid-19): Latest updates and information
Skip to main content Skip to navigation

banner

Introduction

Warwick Screening is a multidisciplinary team of researchers led by Dr Sian Taylor-Phillips. We specialise in evaluating health screening for a variety of conditions. Our work spans primary research, evidence review for national and international policy-makers, and specialist teaching.

CLAHRC

clahrc

CLAHRC (Collaboration for Leadership in Applied Health Research and Care West Midlands) Theme 3: Prevention and Detection works in the area of screening through its work with the National Screening Committee on diseases such as Tyrosinemia Type 1, Group B Strep and NIPT.

Warwick Evidence

evidence

Warwick Evidence has undertaken evaluations of screening and diagnostic technologies that have the potential to improve health outcomes (e.g., screening for cystic fibrosis-related diabetes and type 1 diabetes).

Medicine, Society and Ethics

society

Dr Felicity Boardman in the Medicine, Society and Ethics group focuses on the social and ethical implications of reproductive screening, particularly when used in conjunction with emerging genomic technologies such as whole genome sequencing. Find out more.